Evidence map›Paper›PMID 38264655›Full record

ArticleFrontiers in immunology2023

Species comparison: human and minipig PBMC reactivity under the influence of immunomodulating compounds

Clara P S Pernold, Emil Lagumdzic, Maria Stadler, Marlies Dolezal, Sven Jäckel, Michael W Schmitt, Kerstin H Mair, Armin Saalmüller

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. ATG9 inhibitsAutophagy · 2025
    Article
  3. Review
  4. Immunometabolism of Liver Xenotransplantation and Prospective Solutions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Clara P S PernoldInstitute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.
Emil LagumdzicInstitute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.
Maria StadlerInstitute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.
Marlies DolezalPlatform for Bioinformatics and Biostatistics, Department of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria.
Sven JäckelChemical and Preclinical Safety, Merck KGaA, Darmstadt, Germany.
Michael W SchmittChemical and Preclinical Safety, Merck KGaA, Darmstadt, Germany.
Kerstin H Mair *Institute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.
Armin Saalmüller *Institute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the similarities between swine and humans, it is a logical consequence to use swine as a translational model in research and drug development, including non-clinical safety. Here, we compared the reactivity of peripheral blood mononuclear cells (PBMCs) from humans and minipigs under the influence of different compounds

Indexed as

CD8-Positive T-LymphocytesLeukocytes, MononuclearAbataceptAnimalsHumansImmunosuppressive AgentsReceptors, Antigen, T-CellSirolimusSwineSwine, MiniatureAbataceptImmunosuppressive AgentsReceptors, Antigen, T-CellSirolimuscomparative studyimmunomodulating compoundsin vitro reactivityminipigsproliferation

Identifiers

PMID38264655
PMCPMC10803596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.